Catherine Leport
Biographic Data
| ID | 1731534 |
|---|---|
| NAME | Catherine Leport |
| GIVEN NAMES | Catherine |
| FAMILY NAME | Leport |
| SIGNATURE | LEPORT C |
| AFFILIATIONS | Inserm |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 16 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2002 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 2 |
Discussing HIV Status
Adherence to and Effectiveness of Highly Active Antiretroviral Treatment for HIV Infection
BACKGROUND: It is well established that high adherence to HIV-infected patients on highly active antiretroviral treatment (HAART) is a major determinant of virological and immunologic success. Furthermore, psychosocial research has identified a wide range of adherence factors including patients' subjective beliefs about the effectiveness of HAART. Current statistical approaches, mainly based on the separate identification either of factors associ…
Information That Should Be Given to HIV Cohort Participants during Ongoing Research
While investigators have a duty to provide research participants with summary findings at the end of a study, providing general information during the course of research is rarely considered. However, this raises an important ethical issue in the context of long-term studies such as cohorts or biobanks. We investigated this issue in the context of two ANRS cohorts of HIV-infected patients, AQUITAINE and COPILOTE. Face-to-face interviews were cond…
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy
Adherence to highly active antiretroviral therapies (Haart) in HIV-infected patients
Adherence to highly active antiretroviral therapies (Haart) in HIV-infected patients
Information That Should Be Given to HIV Cohort Participants during Ongoing Research
While investigators have a duty to provide research participants with summary findings at the end of a study, providing general information during the course of research is rarely considered. However, this raises an important ethical issue in the context of long-term studies such as cohorts or biobanks. We investigated this issue in the context of two ANRS cohorts of HIV-infected patients, AQUITAINE and COPILOTE. Face-to-face interviews were cond…
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy
Adherence to highly active antiretroviral therapies (Haart) in HIV-infected patients
Information That Should Be Given to HIV Cohort Participants during Ongoing Research
While investigators have a duty to provide research participants with summary findings at the end of a study, providing general information during the course of research is rarely considered. However, this raises an important ethical issue in the context of long-term studies such as cohorts or biobanks. We investigated this issue in the context of two ANRS cohorts of HIV-infected patients, AQUITAINE and COPILOTE. Face-to-face interviews were cond…
Adherence to and Effectiveness of Highly Active Antiretroviral Treatment for HIV Infection
BACKGROUND: It is well established that high adherence to HIV-infected patients on highly active antiretroviral treatment (HAART) is a major determinant of virological and immunologic success. Furthermore, psychosocial research has identified a wide range of adherence factors including patients' subjective beliefs about the effectiveness of HAART. Current statistical approaches, mainly based on the separate identification either of factors associ…
Discussing HIV Status
HIV/AIDS Research and Interventions (5 works) · Medicine (5 works) · Cohort (4 works) · Cohort study (4 works) · Antiretroviral therapy (3 works) · Family medicine (3 works) · Human immunodeficiency virus (HIV (3 works) · Internal Medicine (3 works) · Psychiatry (3 works) · Viral load (3 works)